Product News

Although only recently identified as a new class of molecules, microRNAs have emerged as a one of the most promising areas of research today. Recent data further suggest that medical conditions, such as cancer, can be associated with specific microRN patterns. Identifying these patterns may lead to the development of targeted treatments.

A major bottleneck in the drug development process is toxicological testing. Traditional in vivo tests performed in animals are difficult to automate; one can't put a rat into a 96-well plate! How does one manage this leg of the development process, where not "failing early" can mean millions of dollars in wasted capital?

It's 10:30 Thursday night. It's been a busy week and I really don't feel like going back up to the lab tonight. Nonetheless, I put on my raincoat and head for the car. It comes with the turf–if you want to offer DNA synthesis at an academic institution, you've got to find a competitive niche.







